Status:
COMPLETED
The Safety of Pharmacopuncture on Musculoskeletal Patients
Lead Sponsor:
Jaseng Medical Foundation
Conditions:
Musculoskeletal Diseases or Conditions
Spine; Arthrosis
Eligibility:
All Genders
19-69 years
Brief Summary
The purpose of this study is to evaluate the safety of pharmacopuncture by observing any adverse events that may occur after pharmacopuncture treatment in with spinal joint disease hospitalized patien...
Detailed Description
This study was an registry observational study, and was conducted in 7 Korean medicine hospitals (160 patients at Jaseng Korean medicine Hospital, 140 patients at Daejeon Jaseng Hospital of Korean Med...
Eligibility Criteria
Inclusion
- Inpatients with diagnosed spinal joint disease
- Patients who received pharmacopuncture treatment during hospitalization
- Patients who are 19 years of age or older and less than 70 years old
- Patients who agreed to participate in the clinical study and voluntarily given written informed consent
Exclusion
- Patients with difficulty or refusal to give sign written informed consent
- Patients for whom the researchers judge participation in the clinical study to be difficult
Key Trial Info
Start Date :
April 27 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 3 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05318859
Start Date
April 27 2022
End Date
February 3 2025
Last Update
September 4 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Daejeon Jaseng Hospital of Korean Medicine
Daejeon, Daejeon, South Korea, 35262
2
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, South Korea, 135-896
3
Bucheon Jaseng Hospital of Korean Medicine
Bucheon-si, Gyeonggi Province, South Korea, 14598
4
Haeundae Jaseng Hospital of Korean Medicine
Busan, South Korea